FDA Approves First Over-the-Counter Naloxone Nasal Spray
The U.S. Food and Drug Administration approved the first naloxone nasal spray product available without a prescription.
Healthcare Interoperability – 2026 Health IT Predictions
As we wrap up another year and get ready for 2026 to begin, it is once again time for everyone’s…
Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury (Remdesivir) for Injection 100 mg/vial Due to the Presence of a Glass Particle
Foster City, Calif., September 20, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced it is issuing a voluntary recall…
TEFCA, Bulk Exchanges, Government Agencies, and Other Advances in Healthcare Interoperability with Jay Nakashima from eHealth Exchange
Jay Nakashima, President at eHealth Exchange, discusses in this video interview some recent hot developments in health data exchange, and…
Moody’s forecasts growing AI threats, regulatory friction for 2026
The report comes as the Trump administration prioritizes deregulating artificial intelligence.
FDA exempts more wearable, AI features from oversight
The regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight…
OpenAI launches health-specific ChatGPT
Users can connect data from their medical records and wellness apps so the chatbot can walk them through test results…
Cyber risks grow as manufacturers turn to AI and cloud systems
Data classification and encryption are essential shields for the highly targeted sector, experts said.